Home › Melanoma › Ohio › Cleveland
Pag-aaral pangklinika para sa Melanoma sa Cleveland, OH
Isang pag-aaral para sa Melanoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Cleveland. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Nagre-recruitPhase 3
- Seidman Cancer Center, Cleveland
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Nagre-recruitPhase 3
- Case Western Reserve University, Cleveland
- UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi ang layo
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Nagre-recruitPhase 2
- Case Western Reserve University, Cleveland
- UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi ang layo
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Nagre-recruitObservasyonal na pag-aaral
- Cleveland Clinic, Cleveland
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Nagre-recruitPhase 1
- Cleveland Clinic, Cleveland
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Nagre-recruitPhase 1/2
- Cleveland Clinic Taussig Cancer Center, Cleveland
Project: Every Child for Younger Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
- Rainbow Babies and Childrens Hospital, Cleveland
- Cleveland Clinic Foundation, Cleveland
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Nagre-recruitPhase 3
- Cole Eye Institute-9500 Euclid Ave, Cleveland
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
Nagre-recruitPhase 1/2
- Cleveland Clinic, Cleveland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mi ang layo
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Cleveland Clinic, Cleveland
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Nagre-recruit
- University Hospitals Cleveland Medical Centre, Cleveland
- University Hospitals Chagrin Highlands Medical Centre, Orange · 12 mi ang layo
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Nagre-recruitPhase 1/2
- Cleveland Clinic, Cleveland
Pag-aaral para sa Melanoma sa ibang lungsod
- Houston, TX59 pag-aaral
- New York City, NY38 pag-aaral
- Los Angeles, CA34 pag-aaral
- Nashville, TN33 pag-aaral
- Pittsburgh, PA31 pag-aaral
- Boston, MA26 pag-aaral
- Philadelphia, PA23 pag-aaral
- San Francisco, CA22 pag-aaral
- Columbus, OH21 pag-aaral
- Durham, NC21 pag-aaral
- Atlanta, GA21 pag-aaral
- Salt Lake City, UT21 pag-aaral
Iba pang pag-aaral sa Cleveland
- Non-Small Cell Lung Cancer43 pag-aaral
- Kanser (lahat ng uri)36 pag-aaral
- Kanser sa Suso35 pag-aaral
- Kanser sa Prostate34 pag-aaral
- Pagkabigo ng Puso33 pag-aaral
- Kanser sa Ovary30 pag-aaral
- Metastatic Cancer30 pag-aaral
- Kanser sa Baga26 pag-aaral
- Colorectal Cancer24 pag-aaral
- Sakit sa Puso at Ugat ng Dugo22 pag-aaral
- Kanser ng Endometrium20 pag-aaral
- Acute Myeloid Leukemia20 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.